In humans, a clinical study [61] comparing the expression of genes involved in bile acid metabolism in NASH and NAFL patients found a downregulated FXR protein expression in NASH patients compared to steatotic ones. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatohepatitis.